Add BrightSurf on Google Email

Three articles in the Journal of Pharmaceutical Analysis uncover previously unknown drug and disease mechanisms

Researchers have identified promising treatment candidates for morphine tolerance and cancer, as well as a biomarker for kidney injury. A monoclonal antibody targeting the mu-opioid receptor has been shown to alleviate morphine tolerance and physical dependence, while inducing excessive mitochondrial fission in tumor cells. Additionall...

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateDec 14, 2023